1/13
09:00 am
dvax
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights
Medium
Report
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights
12/3
01:10 pm
dvax
ACTG Announces Publication of BEe-HIVe Trial in JAMA [Yahoo! Finance]
Low
Report
ACTG Announces Publication of BEe-HIVe Trial in JAMA [Yahoo! Finance]
11/26
04:14 pm
dvax
Dynavax to Present at the 7th Annual Evercore HealthCONx Conference [Yahoo! Finance]
Low
Report
Dynavax to Present at the 7th Annual Evercore HealthCONx Conference [Yahoo! Finance]
11/26
04:05 pm
dvax
Dynavax to Present at the 7th Annual Evercore HealthCONx Conference
Low
Report
Dynavax to Present at the 7th Annual Evercore HealthCONx Conference
11/19
10:12 am
dvax
Uvax Bio Announces Interim Results from a Phase 1 Clinical Trial Evaluating its HIV-1 Vaccine [Yahoo! Finance]
Low
Report
Uvax Bio Announces Interim Results from a Phase 1 Clinical Trial Evaluating its HIV-1 Vaccine [Yahoo! Finance]
11/19
09:04 am
dvax
Dynavax Technologies Corporation (DVAX): This Small-Cap Stock Is Ready To Explode [Yahoo! Finance]
Low
Report
Dynavax Technologies Corporation (DVAX): This Small-Cap Stock Is Ready To Explode [Yahoo! Finance]
11/11
08:00 am
dvax
Dynavax Announces $100 Million Accelerated Share Repurchase Program
Medium
Report
Dynavax Announces $100 Million Accelerated Share Repurchase Program
11/10
09:17 am
dvax
Dynavax Technologies Corporation Just Recorded A 9.1% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
Medium
Report
Dynavax Technologies Corporation Just Recorded A 9.1% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
11/8
12:21 pm
dvax
Dynavax Technologies Corp (DVAX) Q3 2024 Earnings Call Highlights: Record Hep B Sales and ... [Yahoo! Finance]
Low
Report
Dynavax Technologies Corp (DVAX) Q3 2024 Earnings Call Highlights: Record Hep B Sales and ... [Yahoo! Finance]
11/8
08:46 am
dvax
Dynavax Technologies Co. (NASDAQ: DVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $29.00 price target on the stock.
Low
Report
Dynavax Technologies Co. (NASDAQ: DVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $29.00 price target on the stock.
11/7
11:28 pm
dvax
Dynavax Technologies (DVAX) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Dynavax Technologies (DVAX) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
11/7
04:18 pm
dvax
Dynavax Announces $200 Million Share Repurchase Program [Yahoo! Finance]
Medium
Report
Dynavax Announces $200 Million Share Repurchase Program [Yahoo! Finance]
11/7
04:08 pm
dvax
Dynavax GAAP EPS of $0.12 beats by $0.01, revenue of $80.63M misses by $3.54M [Seeking Alpha]
Medium
Report
Dynavax GAAP EPS of $0.12 beats by $0.01, revenue of $80.63M misses by $3.54M [Seeking Alpha]
11/7
04:04 pm
dvax
Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
Medium
Report
Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
11/7
04:02 pm
dvax
Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates
Medium
Report
Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates
11/7
04:01 pm
dvax
Dynavax Announces $200 Million Share Repurchase Program
Medium
Report
Dynavax Announces $200 Million Share Repurchase Program
11/6
01:10 pm
dvax
Glancy Prongay & Murray LLP Announces Investigation of Dynavax Technologies Corporation (DVAX)
Low
Report
Glancy Prongay & Murray LLP Announces Investigation of Dynavax Technologies Corporation (DVAX)
10/29
08:30 am
dvax
Dynavax Adopts Limited-Duration Stockholder Rights Plan
Medium
Report
Dynavax Adopts Limited-Duration Stockholder Rights Plan
10/24
04:10 pm
dvax
Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
Low
Report
Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
10/15
08:47 am
dvax
Dynavax Technologies Co. (NASDAQ: DVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $29.00 price target on the stock.
Low
Report
Dynavax Technologies Co. (NASDAQ: DVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $29.00 price target on the stock.